Posted by Michael Wonder on 31 Mar 2021
Trump gave drug companies a last-minute win on prescription prices. Democrats want Biden to roll it back.
31 March 2021 - The Commerce Department in January proposed barring ‘march in’ actions over high medicine costs.
Two weeks before President Donald Trump left office, his administration bestowed a parting gift on the U.S. prescription drug industry. It proposed a rule to block the government from citing exorbitant prices to seize control of a drug’s production.
